Cerexa Inc.

company

About

Cerexa is a biopharmaceutical company produces a portfolio of anti-infective therapies for the treatment of life-threatening infections.

  • 5001 - 10000

Details

Last Funding Type
Series A
Last Funding Money Raised
$50M
Industries
Biotechnology,Health Care,Medical,Pharmaceutical
Founded date
Jan 1, 2005
Number Of Employee
5001 - 10000
Operating Status
Active

Cerexa is a biopharmaceutical company focused on the development of a portfolio of novel anti-infective therapies for the treatment of serious and life-threatening infections. The company’s product portfolio includes Ceftaroline AcetateCeftaroline, an injectable cephalosporin that is used for the treatment of bacterial infections caused by gram-positive and gram-negative pathogens.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$50M
Cerexa Inc. has raised a total of $50M in funding over 2 rounds. Their latest funding was raised on Aug 23, 2005 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 23, 2005 Series A $50M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Cerexa Inc. is funded by 1 investors. EGS Healthcare Capital Partners are the most recent investors.
Investor Name Lead Investor Funding Round
EGS Healthcare Capital Partners Series A